Summary & Overview
CPT 84999: Unlisted Chemistry Procedure
CPT code 84999 denotes an unlisted chemistry procedure used to report laboratory chemistry tests that lack a specific CPT code. As a catch‑all chemistry code, 84999 ensures procedures without a dedicated code can still be billed and documented, making it important for capturing novel or uncommon assays across clinical laboratories nationally. Use of an unlisted chemistry code affects coding transparency and claims adjudication because payers often require additional documentation to substantiate medical necessity and test specifics.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find national context on how 84999 is applied in laboratory settings, common payer documentation expectations, and the practical implications for claims processing and billing workflows. The report also outlines benchmark considerations, common modifiers associated with laboratory billing, and points of clinical relevance for laboratory managers and billing professionals.
This summary provides a concise overview of the code's purpose and what to expect in the full publication: benchmarking and payment context, payer documentation practices, clinical scenarios where an unlisted chemistry code is used, and administrative considerations for proper claim support. Data not available in the input will be noted where applicable in the main document.
Billing Code Overview
CPT code 84999 is an unlisted chemistry procedure code used to report clinical chemistry services that do not have a specific CPT code. It serves as a catch‑all for laboratory chemistry tests or panels when no existing code accurately describes the performed assay.
-
Service type: Clinical laboratory chemistry testing
-
Typical site of service: Hospital laboratory, independent clinical laboratory, or outpatient laboratory setting
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult referred from primary care or an outpatient specialty clinic for an uncommon or laboratory-developed chemistry assay not represented by an existing CPT code. The patient presents to an ambulatory laboratory or hospital clinical laboratory for phlebotomy. A clinician documents a specific clinical question (for example, rare toxin screen, novel biomarker quantification, or specialized therapeutic drug monitoring) and orders the assay. The specimen is collected (usually blood serum or plasma), labeled, and transported to the laboratory. The laboratory performs the assay using validated methods (mass spectrometry, specialized immunoassay, or molecular-enhanced chemistry) and reports results in the medical record. Billing uses 84999 to report the chemistry procedure when no specific CPT exists. Typical workflow participants include the ordering physician (often internal medicine, medical toxicology, oncology, or infectious disease), phlebotomist, laboratory technologist, and laboratory director who may provide interpretation or verification of results. The usual site of service is an outpatient clinical laboratory or hospital outpatient department, with occasional inpatient use when the assay is clinically necessary during hospitalization. Documentation includes the specimen type, method, clinical indication, test result, and any interpretation or limitations of the assay.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the laboratory documents substantially greater work, e.g., extensive method development or additional steps beyond routine testing. |
26 | Professional component | Use when billing for the laboratory professional component (interpretation/consultation) separate from the technical component. |
52 | Reduced services | Use when the test is partially performed or a reduced service is provided compared with the full assay. |
53 | Discontinued procedure | Use if specimen collection or testing was started but discontinued for clinical reasons. |
59 | Distinct procedural service | Use to indicate a distinct lab procedure when multiple unrelated tests are billed on the same date. |
90 | Reference (outside) laboratory | Use when the specimen was sent to an outside independent reference lab for performance of the assay. |
91 | Repeated clinical diagnostic laboratory test | Use when the same test is repeated on the same day for verification or monitoring. |
TC | Technical component | Use when billing only the technical component of the assay (equipment, technician). |
RT/LT are not in the provided list and therefore not included | Data not applicable | Not applicable |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 208D00000X | Clinical Pathology | Laboratory directors and pathologists overseeing specialized chemistry testing. |
| 207K00000X | Internal Medicine | Ordering clinicians for complex metabolic, toxicologic, or therapeutic drug assays. |
| 207L00000X | Medical Oncology | Ordering specialty for novel biomarkers and chemotherapy drug monitoring. |
| 207X00000X | Infectious Disease | Ordering specialty when specialized chemistry tests aid infectious disease management. |
| 364S00000X | Clinical Laboratory Science/Medical Technologist | Performing technologists and laboratory scientists who run and validate the assay. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
R79.89 | Other specified abnormal findings of blood chemistry | Captures abnormal chemistry findings that prompt or result from specialized assays billed with 84999. |
T36-T50 (group) | Poisoning by, adverse effect of and underdosing of drugs, medicinals and biological substances | Toxicology-related chemistry assays for drug or toxin identification and quantification. |
E86.0 | Dehydration | Metabolic or electrolyte assessments may require specialized chemistry testing in complicated cases. |
E87.6 | Hypokalemia | Electrolyte disorders that may necessitate specialized assays for differential diagnosis or monitoring. |
C80.1 | Malignant neoplasm, unspecified; with metastasis | Oncology-related specialized biomarker assays or drug monitoring when no specific CPT exists. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
36415 | Collection of venous blood by venipuncture | Specimen collection commonly performed before the specialized chemistry assay billed with 84999. |
80053 | Comprehensive metabolic panel | Routine chemistry panel often performed alongside specialized assays to provide baseline metabolic data. |
80307 | Drug test, presumptive, any number of drug classes; performed by high complexity test method | Initial toxicology screening that may precede or supplement a more specialized confirmatory chemistry assay billed with 84999. |
82565 | Creatine kinase (CK), total | Example of specific chemistry tests usually coded with unique CPTs; listed to contrast with 84999 for non-coded assays. |
89398 | Unlisted miscellaneous pathology test | Alternative unlisted code used in pathology/lab contexts when no specific code exists; may be used in workflows involving specialized assays. |